Double-Blind, Placebo-Controlled Study of the Therapeutic Use of Recombinant Human Erythropoietin for Anemia Associated With Chronic Renal Failure in Predialysis Patients

American Journal of Kidney Diseases

Volumn 18, Issue 1, 1991, Pages 50-59

[No Author Info available]

Author keywords

anemia; Chronic renal failure; human recombinant erythropoietin; predialysis patients

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0025866791     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(12)80290-3     Document Type: Article

References (26)

1. Anemia of end-stage renal disease (ESRD)
2. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
3. The anemia of chronic renal failure in sheep: Response to erythropoietinrich plasma in vivo
4. Haemolysis in chronic renal failure
5. The therapeutic equivalence of oral and intravenous iron in renal dialysis patients
6. Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis
7. Inhibition of cell proliferation in renal failure and its significance to the uraemic syndrome: A review
8. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure
9. Erythropoietin-hematocrit feedback circuit in the anemia of end-stage renal disease
10. Purification of human erythropoietin
11. Erythropoietin: Gene cloning, protein structure, and biological properties
12. Recombinant human erythropoietin in hemodialysis patients-Dose determination and clinical experience
13. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis
14. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and phase II clinical trial
15. Wirksamkeit von rekombinantem humanem Erythropoietin in der Behandlung der transfusionsabhangigen Anamie chronischer Dialysepatienten
16. Improvement in the hemostatic defect of uraemia after treatment with recombinant human erythropoietin
17. Therapie der renalen Anamie mit rekombinantem humanem Erythropoietin
18. Erfolgreiche Behandlung der Anamie bei Hamodialyse-Patienten mit rekombiniertem humanem Erythropoietin. Erhaltungsdosis und Serumkonzentration
19. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic hemodialysis
20. Erythropoietin treatment in anaemic patients on haemodialysis
21. Use of ranks in single-criteria variance analysis
22. Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind, placebo-controlled trial
23. Treatment of the anemia of predialysis patients with recombinant human erythropoietin: A randomized, placebo-controlled trial
24. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin
25. Anemia lessons and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass
26. Serum creatinine and renal function